Citation: | LI Hongxue, ZHANG Lei. Analysis of patent applications of heterocyclic compounds in China Pharmaceutical University 2010-2014[J]. Journal of China Pharmaceutical University, 2016, 47(2): 247-250. DOI: 10.11665/j.issn.1000-5048.20160220 |
[1] |
Bai XG,Xu LX,et al.Advance in research of cyclin-dependent kinase 2 inhibitors based on the structures of target proteins [J].Chin New Drugs J(中国新药杂志),2011, 20(17):1667-1672.
|
[2] |
Zhang YH, Peng SX. Advances in the research of nitric oxide-donating drugs[J].J China Pharm Univ(中国药科大学学报),2006,37(5):387-396.
|
[3] |
Jiang SM,Wang ZX.Research progress of Polo-like kinase 1 and prognosis and treatment in human carcinomas[J].Mod Oncol现代肿瘤医学),2013,21(3):650-653.
|
[4] |
Feng F,Liu WY,Guo QL,et al.Anti-tumor QSAR of gambogic acid analogues[J].J China Pharm Univ(中国药科大学学报),2007,38(4):311-314.
|
[5] |
Zhou ZT,Wang JW.PhaseⅠhuman tolerability trial of gambogic acid[J].Chin New Drugs J(中国新药杂志),2007,16(1):79-82.
|
[6] |
Lu T,Lu S,Li HF,et al.Advances and prospects on signal transduction pathways in tumor and R&D of the related drugs(I)[J].J China Pharm Univ(中国药科大学学报),2008,39(3):193-199.
|
[1] | HOU Kai, LI Ping, ZHANG Jinlian, WANG Fang, YANG Yu. Blood coagulation factor XI: new strategy of targeted anticoagulant therapy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 708-714. DOI: 10.11665/j.issn.1000-5048.2023050101 |
[2] | YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202 |
[3] | LIU Yanhong, CHEN Liqing, ZHANG Xintong, GAO Zhonghao, HUANG Wei. Research progress of tumor immunomodulation strategies based on nanodrug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 5-14. DOI: 10.11665/j.issn.1000-5048.2023021501 |
[4] | WANG Yanmei, YANG Lei, XIN Xiaofei, YIN Lifang. Combination therapy and drug delivery strategies for treatment of non-alcoholic fatty liver disease[J]. Journal of China Pharmaceutical University, 2022, 53(4): 423-432. DOI: 10.11665/j.issn.1000-5048.20220405 |
[5] | ZHOU Xinyuan, LIU Nan, ZHANG Pan, HUO Meirong. Advances in research on therapeutic strategies of targeting pancreatic cancer stroma[J]. Journal of China Pharmaceutical University, 2021, 52(6): 653-662. DOI: 10.11665/j.issn.1000-5048.20210602 |
[6] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[7] | YANG Shan, XU Cheng, YAO Jing. Strategies of nano drug delivery system applied in anti-angiogenic therapy[J]. Journal of China Pharmaceutical University, 2019, 50(1): 11-18. DOI: 10.11665/j.issn.1000-5048.20190102 |
[8] | SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402 |
[9] | SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103 |
[10] | KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15. |
1. |
翟允耀,章晓骅. 化学仿制药制剂开发中晶型研究思路探讨. 药品评价. 2024(02): 131-133 .
![]() | |
2. |
梁霖霖,王志伟,何小双,衡伟利,钱帅,高缘,张建军,魏元锋. 机械外力对中药提取物晶体学固态形式及溶出速率的影响研究——以女贞子提取物为例. 中国药科大学学报. 2024(06): 767-774 .
![]() |